Phase II/III Study of the Safety and Effectiveness of HRIG With Active Rabies Vaccine in Healthy Subjects

NCT02040090 · clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
118
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Kamada, Ltd.